ST2预测儿童先天性心脏病术后1年内非计划再入院风险
该前瞻性队列研究纳入145例在约翰霍普金斯医院接受先天性心脏病手术的18岁以下患儿,探讨术前和术后ST2生物标志物水平与术后1年内非计划再入院风险的关系。结果显示,145例中39例在365天内再入院,中位再入院时间54天;
要点
- 术前和术后ST2升高均与先心病术后1年内再入院风险增加相关。
- 再入院中位时间54天,提示早期识别高风险患儿的重要性。
- ST2可用于风险分层或术后预后评估。
核心结论
- 术前和术后ST2水平升高与儿童先天性心脏病术后1年内非计划再入院风险显著增加相关。
研究设计与样本
- 前瞻性队列研究,纳入2010至2014年在约翰霍普金斯医院接受至少1次先心病手术的18岁以下患儿145例。
- 术前和体外循环结束时采集血浆样本,采用Kaplan-Meier生存分析和多因素Cox回归模型调整STS先天性心脏病手术数据库死亡风险模型中的变量。
主要发现
- 145例患儿中39例在365天内再入院,非计划再入院中位时间54天(四分位距10-153)。
- Kaplan-Meier分析显示术前和术后ST2三分位组间再入院风险存在显著差异。
临床怎么用
- ST2可作为儿童先心病术后风险分层或预后评估的新型血清生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Approximately 10% to 20% of children are readmitted after congenital heart surgery. Very little is known about biomarkers as predictors of risk of unplanned readmission after pediatric congenital heart surgery. Novel cardiac biomarker ST2 may be associated with risk of unplanned readmission. ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. Our objective was to explore the relationship between pre- and postoperative ST2 biomarker levels and risk of readmission within 1 year after congenital heart surgery. METHODS: We prospectively enrolled pediatric patients aged < 18 years who underwent at least 1 congenital heart operation at Johns Hopkins Hospital from 2010 to 2014. Plasma samples were collected immediately before surgery and at the end of bypass. We used Kaplan-Meier survival analysis and multivariable Cox regression models to adjust for variables used in The Society of Thoracic Surgeons Congenital Heart Surgery Database mortality risk model. RESULTS: Of our cohort of 145 patients, we found 39 children with readmissions within 365 days. The median time to unplanned readmission was 54 days (interquartile range, 10-153). Kaplan-Meier analysis demonstrated a significant difference across terciles of pre- and postoperative ST2 biomarker levels. After adjustment, elevated serum levels of ST2 measured preoperatively and postoperatively were associated with increased risk of readmission (hazard ratio, 2.5-3.7; all P < .05). CONCLUSIONS: Elevated levels of ST2 are significantly associated with increased risk of unplanned readmission within 1 year after pediatric congenital heart surgery. Novel serum biomarker ST2 can be used for risk stratification or estimating postsurgical prognosis.
引用
- Parker DM, Everett AD, Stabler ME, et al. ST2 Predicts Risk of Unplanned Readmission Within 1 Year After Pediatric Congenital Heart Surgery. Ann Thorac Surg. 2020. PMID: 32246937. doi:10.1016/j.athoracsur.2020.02.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。